Ampersand 2018 Limited Partnership 4
4 · INTERPACE BIOSCIENCES, INC. · Filed Feb 4, 2026
Research Summary
AI-generated summary of this filing
Interpace (IDXG) 10% Owner Converts Preferred Into 13.86M Shares
What Happened
- Ampersand 2018 Limited Partnership (reported as a 10% owner) converted 28,000 shares of Interpace Biosciences' Series C Convertible Preferred Stock into 13,861,386 shares of common stock on January 20, 2026. The conversion is reported at an effective price of $2.02 per share, implying a notional value of $28,000,000. The filing reflects the derivative conversion (acquisition of common stock) and the corresponding disposition of the 28,000 preferred shares (derivative disposal).
Key Details
- Transaction date: January 20, 2026; Filing date: February 4, 2026 (filed 15 days after the transaction).
- Conversion details: 28,000 Series C Preferred → 13,861,386 common shares; conversion price basis $2.02/share; notional value ~$28,000,000.
- Reported as: Conversion of derivative security (Code C) — common shares acquired; preferred shares disposed (derivative).
- Shares owned after transaction: Not specified in this Form 4 filing.
- Notable footnotes:
- Series C preferred converted using stated value $1,000 per preferred share divided by conversion price $2.02 (see F1–F2).
- Securities held of record by Ampersand 2018 LP; related general partners AMCLP and AMCLLC may be deemed to have voting/investment power but disclaim beneficial ownership except for any pecuniary interest (F3–F4).
- Series C preferred had no expiration date (F5).
Context
- This was a conversion of a convertible preferred security into common stock — not an open-market buy or sale. Conversions typically reflect contractual terms of prior financing rather than an active market opinion by the holder.
- Ampersand is an institutional/10% owner entity; the filing includes standard disclaimers that related general partners may be deemed to have control but disclaim beneficial ownership beyond pecuniary interest.
Insider Transaction Report
Form 4
Ampersand 2018 Limited Partnership
10% Owner
Transactions
- Conversion
Common Stock
[F1][F2][F3][F4]2026-01-20$2.02/sh+13,861,386$28,000,000→ 13,861,386 total - Conversion
Series C Convertible Preferred Stock
[F2][F1][F5][F3][F4]2026-01-20−28,000→ 0 totalExercise: $2.02From: 2024-10-11→ Common Stock (13,861,386 underlying)
Footnotes (5)
- [F1]On January 20, 2026, 28,000 shares of the Issuer's Series C Convertible Preferred Stock, par value $0.01 per share (the "Series C Preferred Shares"), were converted into 13,861,386 shares of the Issuer's common stock, par value $0.01 per share (the "Common Stock").
- [F2]The Series C Preferred Shares were convertible into a number of shares of Common Stock equal to the initial stated value per Series C Share of $1,000 divided by the initial conversion price of $2.02 per shares and then multiplied by the number of Series C Preferred Shares to be converted.
- [F3]These securities are held of record by Ampersand 2018 Limited Partnership (the "Investor"). AMP-18 Management Company Limited Partnership ("AMCLP") is the general partner of the Investor, and AMP-18 MC LLC ("AMCLLC") is the general partner of AMCLP. By virtue of such relationships, AMCLP and AMCLLC may be deemed to have voting and investment power with respect to the securities held by the Investor noted above and as a result may be deemed to have beneficial ownership over such securities.
- [F4]Each of the Investor, AMCLP and AMCLLC disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any such entity or person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
- [F5]The Series C Preferred Shares had no expiration date.
Signature
/s/ Dana L. Niles By: Dana L. Niles, Chief Operating Officer of AMP-18 MC LLC|2026-02-04